Microscopic colitis: Clinical characteristics, treatment and outcomes in an Irish population

International Journal of Colorectal Disease

Volumn 29, Issue 7, 2014, Pages 799-803

  O'Toole, Aoibhlinn ^a   Coss, Alan ^a   Holleran, Grainne ^a   Keegan, Denise ^a   Doherty, Glen ^a   Sheahan, Kieran ^a   Mulcahy, Hugh ^a   O'Donoghue, Diarmuid ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Budesonide; Collagenous colitis; Diarrhoea; Drug induced colitis; Lymphocytic colitis; Microscopic colitis

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CELIAC DISEASE; CLINICAL FEATURE; COLLAGENOUS COLITIS; COLON RESECTION; DIARRHEA; FECES INCONTINENCE; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; PRIORITY JOURNAL; REMISSION; SMOKING; TREATMENT OUTCOME; VERY ELDERLY; WEIGHT REDUCTION; COLITIS, MICROSCOPIC; COMPLICATION; FECAL INCONTINENCE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ABDOMINAL PAIN; AGED; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; COLITIS, MICROSCOPIC; DIARRHEA; FECAL INCONTINENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84903316622     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-014-1860-8     Document Type: Article

References (27)

1. Fine KD, Seidel RH, Do K (2000) The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 51(3):318-326 (Pubitemid 30149223)
2. Lindstrom CG (1976) 'Collagenous colitis' withwatery diarrhoea-a new entity? Pathol Eur 11(1):87-89
3. Fine KD, Meyer RL, Lee EL (1997) The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a glutenfree diet. Gastroenterology 112(6):1830-1838 (Pubitemid 27240767)
4. Fine KD et al (2000) High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 95(8):1974-1982
5. Villanacci V, Casella G, Bassotti G (2011) The spectrum of drugrelated colitides: important entities, though frequently overlooked. Dig Liver Dis 43(7):523-528
6. Cappell MS (2004) Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 99(6):1175-1190
7. Chande N, McDonald JW, Macdonald JK (2004) Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials. Am J Gastroenterol 99(12):2459-2465 (Pubitemid 40039379)
8. Kitchen PA et al (2002) Microscopic colitis: the tip of the iceberg? Eur J Gastroenterol Hepatol 14(11):1199-1204 (Pubitemid 35471528)
9. Olesen M et al (2004) Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 53(3):346-350 (Pubitemid 38241327)
10. Pardi DS et al (2002) Microscopic colitis: a review. Am J Gastroenterol 97(4):794-802 (Pubitemid 34408232)
11. Pardi DS et al (2002) Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 97(11):2829-2833 (Pubitemid 35265435)
12. Bohr J et al (1996)Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 39(6):846-851 (Pubitemid 27049088)
13. Zins BJ, Sandborn WJ, Tremaine WJ (1995) Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 90(9):1394-1400
14. Johnston SD et al (1997) Prevalence of coeliac disease in Northern Ireland. Lancet 350(9088):1370 (Pubitemid 28036915)
15. Stewart M et al (2011) The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 33(12):1340-1349
16. Jacobson DL et al (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223-243 (Pubitemid 27398022)
17. Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33(3-4):197-207
18. Fernandez-Banares F et al (2013) Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis 19(2):411-417
19. Capurso G et al (2011) Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospective case-series and systematic review of the literature. Dig Liver Dis 43(5):380-385
20. Riddell RH, Tanaka M, Mazzoleni G (1992) Non-steroidal antiinflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 33(5):683-686
21. Greenberg GR et al (1994) Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med 331(13):836-841
22. Greenberg GR et al (1996) Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 110(1):45-51 (Pubitemid 26021603)
23. Tysk C (2009) Large intestine: remission of lymphocytic colitis with budesonide. Nat Rev Gastroenterol Hepatol 6(9): 506-507
24. Gentile NM et al (2013) Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol 108(2):256-259
25. Miehlke S et al (2014) Budesonide ismore effective thanmesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology. doi:10.1053/j.gastro.2014.01.019
26. Esteve M et al (2011) Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohn's Colitis 5(6):612-618
27. Aram G et al (2010) Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy. Clin Gastroenterol Hepatol 8(4): 391-394